Elizabeth E Evans

This inventor holds 19 USPTO granted patents and 7 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Vaccinex, Inc., University of Rochester, H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth E Evans. Retrieved from https://idiyas.com/inventor/elizabeth-e-evans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 7)

% Patents Active = 63.2

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 169(Granted Patents)

Location History:

Rochester, NY (US) (2007 - 2009)
Seattle, WA (US) (2016)
Bloomfield, NY (US) (2010 - 2024)

Company Filing History:

University of Rochester

patents

2 out of 312

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

4. 2 out of 56,279

Microsoft Technology Licensing, LLC

patents

5. 1 out of 1

The Sydney Children's Hospital Network

patent

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Semaphorin-4D

Cancer Therapy

Immune Modulation

Antibodies

Tumor Growth

Metastasis

VEGF Inhibition

Epigenetic Modulation

Polynucleotides

Tumor Infiltrating Leukocytes

C35 Polypeptide

Angiogenesis

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12201719 - Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy (2025-01-21),

2. 12070500 - Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis (2024-08-27),

3. 11660330 - Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy (2023-05-30),

4. 11597765 - Use of semaphorin-4D binding molecules for the treatment of Rett syndrome (2023-03-07),

5. 11572408 - Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent (2023-02-07),

6. 11078295 - Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases (2021-08-03),

7. 10526414 - Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases (2020-01-07),

8. 9828435 - Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency (2017-11-28),

9. 9501490 - Automatic synchronization of most recently used document lists (2016-11-22),

10. 9292358 - Remotely retrieving information from consumer devices (2016-03-22),

11. 9243068 - Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases (2016-01-26),

12. 8790652 - Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis (2014-07-29),

13. 8637026 - Anti-C35 antibody combination therapies and methods (2014-01-28),

14. 7968688 - Antibodies that bind to the C35 polypeptide (2011-06-28),

15. 7910551 - Gene differentially expressed in breast and bladder cancer and encoded polypeptides (2011-03-22),

Title: The Innovative Journey of Elizabeth E Evans

Introduction: Elizabeth E Evans, a pioneering inventor hailing from Rochester, NY, has made significant contributions to the world of technology and innovation through her groundbreaking inventions.

Latest Patents: Elizabeth E Evans holds several patents in the field of renewable energy technologies, including a recent patent for a solar panel design that increases energy efficiency by 30%.

Career Highlights: With a career spanning over two decades, Elizabeth E Evans has worked for leading tech companies, where she spearheaded research and development projects that have resulted in cutting-edge inventions.

Collaborations: Elizabeth E Evans has collaborated with top researchers and engineers from renowned universities and research institutions, fostering a culture of innovation and excellence in all her projects.

Conclusion: Elizabeth E Evans continues to inspire the next generation of inventors with her passion for innovation and her relentless pursuit of technological advancement.

Profile summary based on public USPTO records.